HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eugenia Girda Selected Research

Nivolumab

7/2022A phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumors.
1/2022Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eugenia Girda Research Topics

Disease

14Neoplasms (Cancer)
05/2024 - 07/2015
7Endometrial Neoplasms (Endometrial Cancer)
06/2023 - 08/2014
3Carcinoma (Carcinomatosis)
11/2022 - 11/2018
2Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2023 - 11/2023
2Diarrhea
01/2023 - 01/2022
2Hemorrhage
01/2022 - 01/2017
1Ovarian Neoplasms (Ovarian Cancer)
05/2024
1Abdominal Pain (Pain, Abdominal)
02/2024
1Teratoma (Teratoid Tumor)
02/2024
1Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational)
08/2023
1Hydatidiform Mole (Molar Pregnancy)
08/2023
1Thrombocytopenia (Thrombopenia)
01/2023
1Uterine Neoplasms (Uterine Cancer)
01/2023
1Melanoma (Melanoma, Malignant)
07/2022
1Fallopian Tube Neoplasms
06/2022
1Ovarian Epithelial Carcinoma
06/2022
1Carcinosarcoma
01/2022
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022
1Mucositis
05/2021
1Glycogen Storage Disease Type VI (Glycogenosis Type VI)
05/2021
1Pain (Aches)
05/2021
1Vaginal Neoplasms (Cancer, Vaginal)
01/2021
1Hematocolpos
01/2021
1Weight Loss (Weight Reduction)
01/2020
1Ascites
01/2020
1Placenta Accreta
01/2017
1Abscess
08/2013
1Pelvic Pain
08/2013

Drug/Important Bio-Agent (IBA)

4Paclitaxel (Taxol)FDA LinkGeneric
06/2023 - 11/2018
3pembrolizumabIBA
05/2024 - 01/2022
3Immune Checkpoint InhibitorsIBA
11/2023 - 05/2021
3Carboplatin (JM8)FDA LinkGeneric
06/2023 - 11/2018
2PlatinumIBA
05/2024 - 06/2022
2NivolumabIBA
07/2022 - 01/2022
1lenvatinibIBA
05/2024
1Peptides (Polypeptides)IBA
02/2024
1Small Interfering RNA (siRNA)IBA
02/2024
1Immunoconjugates (Immunoconjugate)IBA
11/2023
1Phosphotransferases (Kinase)IBA
01/2023
1CreatinineIBA
01/2023
1Cisplatin (Platino)FDA LinkGeneric
01/2023
1adavosertibIBA
01/2023
1talazoparibIBA
11/2022
1RiluzoleFDA LinkGeneric
07/2022
1Glutamic Acid (Glutamate)FDA Link
07/2022
1ProdrugsIBA
07/2022
1EnzymesIBA
01/2022
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2022
1Angiogenesis InhibitorsIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1cabozantinibIBA
01/2022
1Alanine Transaminase (SGPT)IBA
01/2022
1Gabapentin (Neurontin)FDA LinkGeneric
05/2021
1Oxycodone (Oxycontin)FDA LinkGeneric
05/2021
1Prednisone (Sone)FDA LinkGeneric
05/2021
1Oxidoreductases (Dehydrogenase)IBA
07/2015
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
07/2015
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
07/2015
1Anti-Bacterial Agents (Antibiotics)IBA
08/2013

Therapy/Procedure

9Therapeutics
05/2024 - 08/2013
4Drug Therapy (Chemotherapy)
11/2023 - 11/2018
4Radiotherapy
01/2023 - 08/2014
4Hysterectomy
01/2022 - 01/2017
2Immunotherapy
01/2022 - 05/2021
1Laparotomy
02/2024
1Brachytherapy
11/2023
1Injections
06/2022
1Salpingo-oophorectomy
05/2021
1Lymph Node Excision (Lymph Node Dissection)
05/2021
1Surgical Decompression
01/2021
1Decompression
01/2021
1Minimally Invasive Surgical Procedures
01/2020
1Patient Readmission
01/2020
1Length of Stay
01/2020
1Blood Transfusion (Blood Transfusions)
01/2020
1Polypharmacy
07/2015